PUBLIC COMPANY
save$ABBVAbbVie Inc.
$ABBV265.97+2.72%North Chicago, IL, USupdated 6h ago
AbbVie Inc. is an American pharmaceutical company headquartered in North Chicago, Illinois. They have produced drugs to treat a wide range of medical issues.
community read0 votes
🐶 often sniffed alongside
top 8- tagApproval168 co-mentions · 84 sources
- drugHUMIRA122 co-mentions · 61 sources
- drugadalimumab122 co-mentions · 61 sources
- drugABRILADA61 co-mentions · 61 sources
- drugYUSIMRY61 co-mentions · 61 sources
- drugAMJEVITA61 co-mentions · 61 sources
- drugSKYRIZI46 co-mentions · 23 sources
- drugrisankizumab46 co-mentions · 23 sources
pipeline
59
marketed
33
phase 3
3
catalysts ytd
29
approvals ytd
21
recalls ytd
0
Pipeline(59)
view full pipeline →pipeline depth59 products
2Phase 13Phase 23Phase 333Marketed16Unknown2pre_registration
Marketed
(avibactam sodium + aztreonam)
Complicated Intra-Abdominal Infections
Marketed(avibactam sodium + ceftazidime)
Pyelonephritis
Marketed(donepezil hydrochloride + memantine hydrochloride ER)
Dementia Associated With Alzheimer's Disease
Marketed(foscarbidopa + foslevodopa)
Parkinson's Disease
Marketed(glecaprevir + pibrentasvir)
Hepatitis C
MarketedCARIPRAZINE HYDROCHLORIDE
Autism Spectrum Disorder (ASD)
D(2) dopamine receptorD(3) dopamine receptor
MarketedCreon
Exocrine Pancreatic Insufficiency
MarketedLexapro
Generalized Anxiety Disorder (GAD)
MarketedLumigan
Ocular Hypertension
MarketedORIAHNN (COPACKAGED)
MarketedRestasis
Keratoconjunctivitis Sicca (Dry Eye)
Marketedadalimumab
Intermediate Uveitis
Upcoming
Recent(90d)
earnings (2)
Insider activity
source: SEC Form 4open-market buys + sells
routine RSU / option mechanics (6)
- Mar 31, 26grantRAPP EDWARD J · 155 sh
- Mar 31, 26grantQuaggin Susan E · 71 sh
- Mar 31, 26grantAlpern Robert J · 35 sh
- Feb 27, 26tax coverMichael Robert A. · CHAIRMAN OF THE BOARD AND CEO36,523 sh
- Feb 27, 26tax coverStewart Jeffrey Ryan · EVP, CHIEF COMMERCIAL OFFICER23,812 sh
- Feb 27, 26tax coverReents Scott T · EVP, CHIEF FINANCIAL OFFICER21,638 sh
🐶 Hiring Signal
next earnings Oct 29, 2026
Where AbbVie Inc. is staffing up — a leading indicator of pipeline and commercial priorities.
News
- AbbVie shares pressured as Q2 I&I beat falls below investor expectationsAbbVie investors’ sky-high expectations led to a 4% share decline on Friday as the company reported more modest consensus beats than expected.biospace · 19d ago
- Lilly, AbbVie climb aboard in vivo CAR T train—but safety remains a hurdleSafety will be the key determinant of in vivo CAR T therapies, according to H.C. Wainwright’s Mitchel Kapoor, who noted that convenience and efficacy won’t be enough to impress investors in this sp…biospace · 23d ago
Data sources
last refreshed 3m ago
Found something off?
comments(0)
5-min edit window · permanent after that